Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
NCT07581145
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Foot Ulcer Due to Type 2 Diabetes Mellitus
Interventions
DRUG:
Semaglutide, 1.34 mg/mL
DRUG:
Placebo
Sponsor
Ole Lander Svendsen